What is KPV?
KPV is a tripeptide made of lysine, proline and valine. It matches the last three amino acids (positions 11 to 13) of alpha-melanocyte-stimulating hormone (alpha-MSH), a hormone with known anti-inflammatory activity. KPV has been studied in cell and animal models of inflammation, including mouse models of colitis (Dalmasso et al., Gastroenterology, 2008).
KPV product specifications
- Compound: KPV (alpha-MSH 11-13)
- Sequence: Lys-Pro-Val (KPV, 3 amino acids)
- Molecular formula: C16H30N4O4
- Molecular weight: about 342.4 g/mol
- Vial sizes: 4mg and 10mg
Regulatory status
KPV is not an approved medicine in the US, UK, EU or Canada and has no published human clinical trials. This product is sold for laboratory research use only.
Related research peptides
- LL-37 is a human peptide studied in immune and inflammation research.
- ARA-290 is another peptide studied in inflammation models.
Available sizes: 4mg and 10mg
KPV is offered in two vial sizes: 4mg and 10mg. Both contain the same peptide. The figure is the total amount of peptide in the vial, supplied as a dry (lyophilised) powder; it is not a concentration, so a larger vial is not “stronger”, it simply holds more material. Tell us which size you need when you contact us on Telegram or by email.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
